Source: Google NewsPublished on 2020-12-24
Related Articles:
- Update on COVID-19 and Parkinson’s disease October 27, 2020 Latest Research on COVID-19 & Parkinson’s disease UPDATE: This post (originally published in June) has been updated with the latest information available. We will continue to keep this post up-to-date as new information develops. As citizens of the world, we all continue to grapple with the COVID-19 pandemic. And as members of the Parkinson’s disease (PD) community, we continue to have…
- Update on COVID-19 and Parkinson’s disease October 27, 2020 Latest Research on COVID-19 & Parkinson’s disease UPDATE: This post (originally published in June) has been updated with the latest information available. We will continue to keep this post up-to-date as new information develops. As citizens of the world, we all continue to grapple with the COVID-19 pandemic. And as members of the Parkinson’s disease (PD) community, we continue to have…
- Life with Parkinson’s in the Time of COVID-19: April is Parkinson’s Awareness Month April 1, 2020 “The measure of who we are is what we do with what we have.” Vince Lombardi “When you have exhausted all possibilities, remember this: you haven’t.” Thomas Edison Précis: A different world exists today than it did just a few weeks ago, all driven by the COVID-19 pandemic. The virus seemingly favors the elderly who have a pre-existing disease(s); however,…
- Life with Parkinson’s in the Time of COVID-19: April is Parkinson’s Awareness Month April 1, 2020 “The measure of who we are is what we do with what we have.” Vince Lombardi “When you have exhausted all possibilities, remember this: you haven’t.” Thomas Edison Précis: A different world exists today than it did just a few weeks ago, all driven by the COVID-19 pandemic. The virus seemingly favors the elderly who have a pre-existing disease(s); however,…
- Prevail lands on a Lilly pad December 15, 2020 # # # # 2020 has been a dreadful year for most of the world – burdened by the outbreak and consequences of COVID-19. Despite this, there has been a steady stream of biotech acquisitions related to Parkinson’s which have helped to keep morale high in the PD research community. In October alone, we saw the Portuguese pharmaceutical company Bial…
- Bayer doubles down on Parkinson’s? December 10, 2020 # # # # News today of two biotech companies merging did not cause much of a ripple in the media, but the wider implications of the move are rather significant for Parkinson’s. Today it was announced that Brain Neurotherapy Bio (BNB) is going to merge with Asklepios Biopharmaceutical (aka AskBio). BNB are currently clinically testing a GDNF gene therapy…
- Answering Your Questions about Parkinson’s disease and Coronavirus Disease 2019 (COVID-19) December 21, 2020 Answering Your Questions about Parkinson’s disease and Coronavirus Disease 2019 (COVID-19) – Updated People with Parkinson’s disease (PD) have been asking a lot of questions about COVID-19 since the pandemic began and APDA has been here with the answers you need. As such, we have updated our blog post again with additional questions that have come in, along with some new information…
- A new reason to hate mosquitos? September 24, 2019 Theories of viral agents as possible causal (or influencing) factors in Parkinson’s have long existed. This week a research team from Colorado in the USA published a new report demonstrating that mice infected with a mosquito-borne alphavirus (called Western equine encephalitis virus) develop Parkinson’s-like features. These features include the loss of dopamine neurons, increased neuroinflammation, locomotor issues, and the…
- A plutocratic proposal: iCancer February 2, 2020 Speeding up the clinical development process is a shared goal across many medical conditions (not just Parkinson’s and neurodegeneration), and there are many different approaches to achieving this that are being explored. Some of these approaches could be considered to be bordering on the unethical, but there are aspects of their structure and design that are still worthy of…
- Covid-19 could be “a perfect storm for Parkinson’s disease”, researchers report October 29, 2020 A new commentary, based on three patient case studies, outlines a potential link between Covid-19 and Parkinson’s disease-like symptoms – and suggests that the virus could be associated with a higher risk of developing the neurological condition A new article, ‘Is COVID-19 a Perfect Storm for Parkinson’s Disease?’, has suggested that contracting the Covid-19 virus could increase the long-term risk…
- Researchers Think COVID-19 May Increase Parkinson’s Risk, Pointing to Need for Detailed Record-keeping May 15, 2020 Although there isn’t currently sufficient evidence to draw definitive conclusions, it is possible that people who survive COVID-19 may be at increased risk of Parkinson’s disease, researchers from Brazil argued in a recent paper. More research is needed to examine this idea, which points to a need for detailed record-keeping by healthcare systems during and after the pandemic. The paper,…
- COVID-19: State's seven-day average increases; 29 more Oklahomans die of coronavirus in latest reporting - Tulsa World December 26, 2020 COVID-19: State's seven-day average increases; 29 more Oklahomans die of coronavirus in latest reporting Tulsa World
- Technology Has Broken Healthcare Barriers During the COVID-19 Pandemic December 29, 2020 COVID-19 has prompted clinicians to change how they deliver care and to reallocate resources toward the most urgent needs on a global scale.1 Patients with diseases ranging from Parkinson disease to chronic pain have been forced to wait for extended periods of time for necessary interventions and treatments. Consequently, many have experienced higher levels of pain, depression, and an overall…
- TGF-beta: The Parkinson’s superfamily? December 12, 2020 # # # # A lot of Parkinson’s research has focused on a neurotrophic factor called glial cell-derived neurotrophic factor (or GDNF). But GDNF only represents a small fraction of a much larger class of neurotrophic factors, called the Transforming growth factor-β (TGF-β) superfamily. Recently, researchers have been investigating some of the other TGF-β family members in preclinical models of…
- COVID-19 Exacerbates Some Parkinson’s Symptoms, Study Finds June 2, 2020 COVID-19 infection appears to worsen some symptoms of Parkinson’s disease, requiring adjustments to therapy, according to a recent case study. The study, “Effects of COVID-19 on Parkinson’s disease clinical features: a community-based case-control study,” was published in the journal Movement Disorders. SARS-CoV-2, the strain of coronavirus responsible for COVID-19 disease, may worsen Parkinson’s disease through several different mechanisms, such as…
- Journey With Parkinson’s: (Part 2) A Different Side of Life November 2, 2020 “Yesterday is but today’s memory, and tomorrow is today’s dream.” Khalil Gibran “Time is free, but it’s priceless. You can’t own it, but you can use it. You can’t keep it, but you can spend it. Once you’ve lost it you can never get it back.” Harvey Mackay Introduction: I am a scientist, trained as a protein chemist with expertise…
- Journey With Parkinson’s: (Part 2) A Different Side of Life November 2, 2020 “Yesterday is but today’s memory, and tomorrow is today’s dream.” Khalil Gibran “Time is free, but it’s priceless. You can’t own it, but you can use it. You can’t keep it, but you can spend it. Once you’ve lost it you can never get it back.” Harvey Mackay Introduction: I am a scientist, trained as a protein chemist with expertise…
- Coronavirus - and how to avoid it March 15, 2020 Sunday 15 March 2020Viruses are remarkable things. Little more than a fragment of DNA or RNA wrapped in a few proteins, they defy the normal view of a lifeform. A virus on its own is essentially dead – it does not breathe or assimilate anything; it has no nervous system or blood flow, or any function that we would associate…
- Monthly Research Review – November 2020 November 30, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- Coronavirus! March 15, 2020 Sunday 15 March 2020Viruses are remarkable things. Little more than a fragment of DNA or RNA wrapped in a few proteins, they defy the normal view of a lifeform. A virus on its own is essentially dead – it does not breathe or assimilate anything; it has no nervous system or blood flow, or any function that we would associate…
- COVID-19 May Compound the Social and Economic Burdens of Parkinson’s Disease May 12, 2020 The potential long-term neurological manifestations of COVID-19 infection are unknown. However, clinical symptoms like the loss of smell and taste and encephalitis suggest that the SARS-CoV-2 virus might have the ability to invade the central nervous system. “The interesting aspect of the olfactory pathway hypothesis for SARS-CoV-2 neuroinvasion is the potential presence of the virus in the brainstem, which contains…
- COVID-19 May Compound the Social and Economic Burdens of Parkinson’s Disease May 12, 2020 The potential long-term neurological manifestations of COVID-19 infection are unknown. However, clinical symptoms like the loss of smell and taste and encephalitis suggest that the SARS-CoV-2 virus might have the ability to invade the central nervous system. “The interesting aspect of the olfactory pathway hypothesis for SARS-CoV-2 neuroinvasion is the potential presence of the virus in the brainstem, which contains…